MIRA INFORM REPORT

 

 

Report Date :

03.06.2011

 

IDENTIFICATION DETAILS

 

Name :

EXCEL CROP CARE LIMITED (w.e.f 30th January, 2003)

 

 

Formerly Known As :

WEST COAST OXYGEN LIMITED

 

 

Registered Office :

184-87, Swami Vivekanand Road, Jogeshwari (West), Mumbai – 400 102, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

21.03.1964

 

 

Com. Reg. No.:

11-012878

 

 

Capital Investment / Paid-up Capital :

Rs.55.028 millions

 

 

CIN No.:

[Company Identification No.]

L74999MH1964PLC012878

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUME04609D

 

 

PAN No.:

[Permanent Account No.]

AAACW3810D

 

 

Legal Form :

A Public Limited Liability Company. Company’s shares are listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturer and Trader of Pesticides.

 

 

No. of Employees :

1218 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (58)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 6752000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having fine track. Financial position of the company appears to be sound. Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

INFORMATION PARTED BY

 

Name :

Mr. Murthi

Designation :

Accountant

Date :

02.06.2011

 

 

LOCATIONS

 

Registered/ Head Office :

184-87, Swami Vivekanand Road, Jogeshwari (West), Mumbai – 400 102, Maharashtra, India

Tel. No.:

91-22-42522200

Fax No.:

91-22-28713037

E-Mail :

eccl@excelcropcare.com

pravin@excelcropcare.com

Website :

http://www.excelcropcare.com

Location :

Owned

 

 

Corporate Office :

13 and 14, Aradhana Industrial Development Corporation, Near Virwani Industrial Estate, Goregaon (East), Mumbai – 400 063, Maharashtra, India

Tel. No.:

91-22-42522200

Fax No.:

91-22-28713037/ 28712523

E-Mail :

eccl@excelcropcare.com

 

 

Manufacturing Units / Factory 1:

Plot No. 60, B, Nanji Industrial Estate, Kharadpada, Silvassa – 396 230, Union Territory of Dadra and Nagar Haveli, India

 

 

Manufacturing Units / Factory 2:

6/2, Ruvapari Road, Bhavnagar – 364 005, Gujarat, India

Tel. No.:

91-278-2212401-2

Fax No.:

91-278-2212410

E-Mail :

bhavcel@excelcropcare.com

 

 

Manufacturing Units / Factory 3:

Kaira Gajod Highway, Gajod, Kutch 

 

 

Windmills :

Located at:

§        Plot No. A/2, Village Dhank, Taluka Upleta, District Rajkot

§        Survey No. 160, Village Navadra, Taluka Kalyanpur, District Jamnagar

§        Survey No. 16/1, Jodhpur, District Jamnagar

 

 

Zonal Offices:

Located at:

 

§        Indore

§        Ahmedabad

§        Delhi

§        Kolkata

§        Secunderabad

 

 

Branch Office :

Located at:

 

v      Akola

v      Cuttack

v      Gulbarga

v      Guwahati

v      Hissar

v      Hubli

v      Indore

v      Jabalpur

v      Jaipur

v      Kottayam

v      Madurai

v      Ludhiana

v      Punjab

v      Parwanoo

v      Patna

v      Pune

v      Raipur

v      Ranchi

v      Siliguri

v      Srigangangar

v      Uttar Pradesh

 

 

International Office:

Excel Industries (Europe) NV

Uitbriedingstraat 84/3, 2600 Antwerpen – Berchem, Belgium, BTW Nr.: BE 450885001

Tel. No.:

+32-3-5425722

Fax No.:

+32-3-2323735

E-Mail :

prataap.taneja@excelcropcare.com

 

 

DIRECTORS

 

As on 31.03.2010

 

Name :

Mr. A. C. Shroff

Designation :

Chairman

Date of Birth/ Age :

22.01.1945

Qualification :

B. Sc.

Experience :

Chemicals and Agro Chemicals Industry

Other Directorship :

v      Excel Industries Limited

v      Transpek Industry Limited

v      Transpek Silox Industry Limited

v      Kamaliyot Investments Limited

v      Phthalo Colours and Chemicals (India) Limited

v      ECCL Investments and Finance Limited

v      Waxsam Limited, Hong Kong

v      Centre for Bharatiya Management Development

v      Indian Centre for Climate and Societal Impacts Research

 

 

Name :

Mr. Dipesh K. Shroff

Designation :

Managing Director

Date of Birth/ Age :

50 Years

Qualification :

Diploma in Civil Engineering

Experience :

29 Years

Date of Appointment :

01.09.2003

 

 

Name :

Mr. Prakash K. Shroff 

Designation :

Executive Director

Date of Birth/ Age :

64 Years

Qualification :

Diploma in Electrical Engineering

Experience :

41 Years

Date of Appointment :

01.09.2003

 

 

Name :

Mr. J. R. Naik

Designation :

Director

Date of Birth/ Age :

23.09.1958

Qualification :

F.C.A.

Experience :

Accounting, Audit, Finance, Taxation, Corporate Law

Other Directorship :

v      Punjab Chemicals and Crop Protection Limited

v      Agrocel Industries Limited

v      Divakar Chemicals Limited

v      Acrysil Limited

v      Good Rasayan Limited

v      Excel Industries (Europe) N.V.

v      Anshul Speciality Molecules Limited

v      Kutch Crop Services Limited

v      ECCL Investments and Finance Limited

 

 

Name :

Dr. Mukul G. Asher

Designation :

Director

Date of Birth/ Age :

17.12.1943

Qualification :

Economics, Public Finance and Social Security

Experience :

B.A. (Hons.), M.A., Ph.D.

Date of Appointment :

03.09.2003

Other Directorship :

UTI International (Singapore) Private Limited

Aditya Birla Sun Life Asset Management Company Pte. Limited, Singapore

Candor RE Management Company, Mauritius

 

 

Name :

Mr. Sandeep Junnarkar 

Designation :

Director

Date of Birth/Age :

02.07.1951

Qualification :

B. Sc. (Hons), LL. B.

Date of Appointment :

03.09.2003

Other Directorships :

v      Everest Industries Limited

v      IL and FS Infrastructure Development Corporation Limited

v      Jai Corporation Limited

v      Jai Realty Ventures Limited

v      Reliance Industrial Infrastructure Limited

v      Reliance Industrial Investments and Holdings Limited

v      Reliance Ports and Terminals Limited

v      Sterlite Energy Limited

v      Sterlite Industries (India) Limited

v      Sunshield Chemicals Limited

v      The Bombay Incorporated Law Society

 

 

Name :

Mr. B. V. Bhargava

Designation :

Director

Date of Birth/Age :

16.04.1936

Qualification :

M. Com., LL. B.

Experience :

Development Banking, Project Finance and Credit Rating

Date of Appointment :

29.10.2003

Other Directorships :

v      CRISIL Limited

v      Grasim Industries Limited

v      ICICI Lombard General Insurance Company Limited

v      J. K. Lakshmi Cement Limited

v      Supreme Industries Limited

v      L and T Infrastructure Finance Company Limited

v      Grasim Bhiwani Textiles Limited

v      Lakshmi Precision Screws Limited

 

 

Name :

Mr. Kevin Martin

Designation :

Director

 

 

Name :

Mr. Sharad L. Patel

Designation :

Director

 

 

Name :

Mr. Vinayak B. Buch

Designation :

Director

Date of Birth :

21.02.1940

Qualification :

Master’s Degree in Economics and Econometrics

Experience :

Public Administration and Management

Other Directorship :

v      Steel Cast Limited

v      Agrocel Industries Limited

 

 

Name :

Mr. Deepak Bhimani

Designation :

Director

Date of Birth :

31.08.1939

Qualification :

Post Graduate in Textile Chemistry

Experience :

Chemicals

Other Directorship :

v      Jayant Agro Organics Limited

 

 

Name :

Mr. Ninad D. Gupte

Designation :

Director

Date of Birth :

31.08.1953

Qualification :

B.Sc., PGDBM (XLRI – Jamshedpur)

Experience :

Commercial functions, Corporate Management and Indirect Taxes

Date of Appointment :

03.12.2008

Other Directorship :

v      Crop Care Federation of India

v      Transpek Industry Limited

v      Agrocel Industries Limited

v      TML Industries Limited

v      Excel Genetics Limited

v      Transpek Industry (Europe) Limited

 

 

Name :

Mr. L. Rajagopalan

Designation :

Alternate Director of Dr. Mukul G Asher

 

 

KEY EXECUTIVES

 

Name :

Mr. Pravin D. Desai

Designation :

Vice President (Finance and Accounts) and Company Secretary

 

 

Name :

Mr. Murthi

Designation :

Accountant

 

 

Name :

Mr. Ashok K. Jain

Designation :

Senior Vice President (R and D and Operations)

Date of Birth/ Age :

59 Years

Qualification :

B. Chem. Eng. (BUDCT)

Experience :

35 Years

Date of Appointment :

01.09.2003

 

 

Name :

Mr. K. Srinivasan

Designation :

Senior Vice President (Finance and Accounts)

Date of Birth/ Age :

60 Years

Qualification :

B.Com. (Hons.), FCA, FCS

Experience :

36 Years

Date of Appointment :

01.09.2003

 

 

Name :

Mr. R. Hariharan

Designation :

Vice President (International Business)

Date of Birth/ Age :

44 Years

Qualification :

B.Sc., MBA (International Marketing)

Experience :

23 Years

Date of Appointment :

01.09.2003

 

 

Name :

Mr. V. P. Rathod

Designation :

Vice President (Seeds Business)

Date of Birth/ Age :

61 Years

Qualification :

B.Sc.

Experience :

38 Years

Date of Appointment :

01.09.2003

 

 

Name :

Mr. Anil Kadian

Designation :

General Manager

Date of Birth/ Age :

50 Years

Qualification :

M.Sc. (Agri.) MBA (Marketing)

Experience :

24 Years

Date of Appointment :

17.04.2006

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 31.03.2011

 

Category of Shareholders

No. of Shares

Percentage of Holding

(A) Shareholding of Promoter and Promoter Group

 

 

(1) Indian

 

 

Individuals / Hindu Undivided Family

427,048

3.88

Bodies Corporate

1,610,111

14.63

Sub Total

2,037,159

18.51

(2) Foreign

 

 

Individuals (Non-Residents Individuals / Foreign Individuals)

81,830

0.74

Sub Total

81,830

0.74

Total shareholding of Promoter and Promoter Group (A)

2,118,989

19.25

(B) Public Shareholding

 

 

(1) Institutions

 

 

Mutual Funds / UTI

294,686

2.68

Financial Institutions / Banks

5,021

0.05

Insurance Companies

1,017,757

9.25

Foreign Institutional Investors

353,210

3.21

Sub Total

1,670,674

15.18

(2) Non-Institutions

 

 

Bodies Corporate

515,221

4.68

Individuals

 

 

Individual shareholders holding nominal share capital up to Rs.0.100 million

4,209,624

38.25

Individual shareholders holding nominal share capital in excess of Rs.0.100 million

726,093

6.60

Any Others (Specify)

1,765,029

16.04

Non Resident Indians

148,029

1.35

Foreign Corporate Bodies

1,617,000

14.69

Sub Total

7,215,967

65.57

Total Public shareholding (B)

8,886,641

80.75

Total (A)+(B)

11,005,630

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

-

-

(1) Promoter and Promoter Group

-

-

(2) Public

-

-

Sub Total

-

-

Total (A)+(B)+(C)

11,005,630

-

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Trader of Pesticides.

 

 

Products :

 

ITC Code

Product Description

3808.91.31

Endosulfan

3808.93.50

Glyphosate

3808.91.99

Chlorpyriphos Technical

 

v      Insecticides

v      Herbicides

v      Fungicides

v      Lumigants

v      Rodenticides

v      Fumigants

v      Seeds

v      Biologicals

v      Fishery Segment

 

 

Terms :

 

Selling :

Depend

 

 

Purchasing :

Depend

 

PRODUCTION STATUS (As on 31.03.2010)

 

Particulars

Unit

Licensed Capacity

Installed Capacity

Actual Production

Pesticides

Tonnes

25900

20750

14519

Pesticides Intermediates

Tonnes

*11000

6900

4449

 

Notes:

(a) Installed Capacity is as certified by the Executive Director on which the Auditors have relied, being a technical matter.

 

(b) Production includes quantities produced for internal consumption and excludes reprocessed material.

 

*(c) Includes capacity as acknowledged by Directorate General of Technical Development/ Secretariat for Industrial Approvals, Capacity being intimated to Secretariat for Industrial Approvals, for acknowledgement.

 

(d) Production excludes formulations produced out of captive/bought out Technical grade material.

 

(e) Production is inclusive of subcontracted production.

 

GENERAL INFORMATION

 

Suppliers :

v      Aryan Paper Containers

v      Dimple Drums and Barrels Limited

v      Hindcomp Private Limited

v      Mullackal Polymers

v      Unitop Chemicals Private Limited

v      Bharat Tin Works

v      Packaging Remedies

v      Omni Cans and Printers Private Limited

 

 

Customers :

Chemical Companies and Manufacturer

 

 

No. of Employees :

1218 (Approximately)

 

 

Bankers :

v      Bank of India

v      Syndicate Bank

v      State Bank of India

v      Citibank N.A.

v      Axis Bank

v      Standard Chartered Bank

v      ICICI Bank Limited

 

 

Facilities :

Secured Loans

31.03.2010

Rs. In Millions

31.03.2009

Rs. In Millions

1. From Banks:

 

 

(a) On Working Capital Demand Loan/Term Loan Accounts

200.000

67.494

(b) On Cash Credit Accounts

288.973

702.517

(c) Under Vehicle Finance

(Note Nos. 1 and 2)

1.675

8.636

2. From Others under Vehicle Finance Scheme

(Note No. 2)

9.627

11.915

Total

500.275

790.562

 

Notes:

1. Loans from Banks on Cash Credit and Working Capital Demand Loan/Term Loan Accounts are secured by way of hypothecation of all tangible movable assets, both present and future, including stock of raw materials, finished goods, goods-in-process, stores, book debts etc.

2. Term Loans under Vehicle Finance from banks and from others for purchase of vehicles amounting to Rs.1.675 millions (Previous Year: Rs.8.636 millions) and Rs.9.627 millions (Previous Year: Rs.11.915 millions) respectively are secured by an exclusive charge by way of hypothecation of cars purchased under the said Schemes.

 

Unsecured Loans

31.03.2010

Rs. In Millions

31.03.2009

Rs. In Millions

Short Term Loans from Banks

953.182

689.183

Total

953.182

689.183

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S.R. Batliboi and Company  

Chartered Accountants 

 

 

Joint Venture :

v      Multichem Industries (a partnership firm)

 

 

Subsidiaries :

v      Excel Industries (Australia) Pty Limited

v      Excel Industries (Europe) N.V.

v      ECCL Investments and Finance Limited

v      Excel Genetics Limited (formerly Harvest Inte-Agro Limited) (w.e.f. 10 August 2009)

 

 

Associates :

v      Aimco Pesticides Limited

v      Excel Bio Resources Limited

v      Kutch Crop Services Limited

 

 

Enterprises over which key management personnel and their relatives have significant influence :

v      Agrocel Industries Limited

v      Anshul Specialty Molecules Limited

v      C. C. Shroff Research Institute

v      C. C. Shroff Self Help Centre

v      Dipkanti Investments and Financing Private Limited

v      Divakar Chemicals Limited

v      Excel Industries Limited

v      Hyderabad Chemicals Limited

v      Hyderabad Chemical Products Limited

v      Parul Chemicals Limited

v      Pritami Investments Private Limited

v      Shroff Family Charitable Trust

v      Shroffs Foundation Trust

v      Shrujan

v      Shrodip Investments Private Limited

v      TML Industries Limited (Formerly Transmetal Limited)

v      Transpek Industry Limited

v      Transpek Industry (Europe) Limited

v      Utkarsh Chemicals Private Limited

v      Shree Vivekanand Research and Training Institute

 

 

CAPITAL STRUCTURE

 

As on 31.03.2010

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

12000000

Equity Shares

Rs.5/- each

Rs.60.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

11005630

Equity Shares

Rs.5/- each

Rs.55.028 millions

 

 

 

 

 

Note:

Of the above,

(a) 92,000 Equity Shares of Rs. 5/- each fully paid-up have been issued by way of Bonus Shares by capitalisation of the surplus in the Profit and Loss Account.

(b) 1,09,05,630 Equity Shares of Rs. 5/- each fully paid-up have been issued pursuant to a Scheme of Arrangement, without payments being received in cash.


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

55.028

55.028

55.028

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

1633.041

1338.906

1125.282

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

1688.069

1393.934

1180.310

 

 

 

 

DEFERRED GOVERNMENT GRANTS

4.673

5.405

6.137

 

 

 

 

LOAN FUNDS

 

 

 

1] Secured Loans

500.275

790.562

733.031

2] Unsecured Loans

953.182

689.183

508.634

TOTAL BORROWING

1453.457

1479.745

1241.665

DEFERRED TAX LIABILITIES

137.680

137.753

124.545

 

 

 

 

TOTAL

3283.879

3016.837

2552.657

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

1072.010

1002.130

884.862

Capital work-in-progress including capital advances

23.745

15.695

9.722

 

 

 

 

INTANGIBLE ASSETS

7.791

10.859

12.360

 

 

 

 

INVESTMENT

26.595

33.814

63.357

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

1429.827
1300.014
931.389

 

Sundry Debtors

1647.449
1317.771
1135.656

 

Cash & Bank Balances

109.385
121.532
132.633

 

Other Current Assets

58.913
80.006
72.886

 

Loans & Advances

412.267
387.173
403.005

Total Current Assets

3657.841
3206.496

2675.569

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

1094.581

883.916

811.047

 

Other Current Liabilities

216.660
198.633
140.812

 

Provisions

192.862
169.608
141.354

Total Current Liabilities

1504.103
1252.157

1093.213

Net Current Assets

2153.738
1954.339

1582.356

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

3283.879

3016.837

2552.657

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.2008

 

SALES

 

 

 

 

 

Sale of Products (Net)

6204.073

6850.997

4859.344

 

 

Other Income from Operations

227.500

287.758

178.867

 

 

Other Income

14.017

3.268

4.616

 

 

TOTAL                                     (A)

6445.590

7142.023

5042.827

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Manufacturing and Other Expenses

5856.388

6678.835

4573.795

 

 

(Increase)/Decrease in Stocks

(169.677)

(225.870)

(93.916)

 

 

Amortisation of Intangible Assets

8.713

12.173

15.753

 

 

TOTAL                                     (B)

5695.424

6465.138

4495.632

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

750.166

676.885

547.195

 

 

 

 

 

Less

INTEREST                                                                 (D)

89.967

149.890

99.261

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

660.199

526.995

447.934

 

 

 

 

 

Less/ Add

DEPRECIATION                                                  (F)

88.291

80.957

71.567

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

571.908

446.038

376.367

 

 

 

 

 

Less

TAX                                                                  (H)

198.527

167.408

129.388

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

373.381

278.630

246.979

 

 

 

 

 

 

Less: Prior Period Adjustments (Net)

 

 

 

 

(a) Taxation

(5.293)

(0.258)

--

 

(b) Others

4.330

0.884

12.746

 

 

 

 

 

 

Add: Debenture Redemption Reserve written back

--

--

6.032

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

107.660

94.036

68.151

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Proposed Dividend

68.785

55.028

55.028

 

 

 

Tax on Distributed Profits

11.424

9.352

9.352

 

 

 

Transfer to General Reserve

300.000

200.000

150.000

 

 

BALANCE CARRIED TO THE B/S

101.795

107.660

94.036

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export of Goods on F.O.B. basis

2094.356

2876.242

1769.628

 

 

Other Income (including interest)

4.695

0.002

0.000

 

TOTAL EARNINGS

2099.051

2876.244

1769.628

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

1478.619

2315.936

1297.657

 

 

Packing Materials

1.259

0.000

3.761

 

 

Components and Spare Parts

8.144

1.709

0.783

 

 

Capital Goods

3.101

3.607

17.601

 

 

Traded Finished Goods

37.856

1.826

0.000

 

TOTAL IMPORTS

1528.979

2323.078

1319.802

 

 

 

 

 

 

Earnings Per Share (Rs.)

34.01

25.26

21.28

 

Particulars

 

 

 

31.03.2011

(Approximately)

Sales Turnover

 

 

7500.000

 

 

 

 

 

The above information has been parted by Mr. Murthi (Accountant).

 

QUARTERLY RESULTS

 

PARTICULARS

 

30.06.2010

30.09.2010

31.12.2010

31.03.2011

Type

1st Quarter

2nd Quarter

3rd Quarter

4th Quarter

Net Sales

2033.730

2302.100

1510.460

1465.200

Total Expenditure

1732.170

1972.710

1365.170

1342.860

PBIDT (Excl OI)

301.560

329.390

145.290

122.340

Other Income

3.610

3.640

3.510

6.240

Operating Profit

305.170

333.030

148.800

128.580

Interest

23.400

16.480

17.140

24.520

Exceptional Items

0.000

0.000

0.000

(102.000)

PBDT

281.770

316.540

131.660

2.070

Depreciation

24.630

24.640

23.850

36.390

Profit Before Tax

257.140

291.900

107.810

(34.320)

Tax

81.500

84.300

32.600

(15.210)

Provisions and contingencies

0.000

0.000

00

0.000

Profit After Tax

175.640

207.600

75.210

(19.110)

Extraordinary Items

0.000

0.000

0.000

0.000

Prior Period Expenses

0.340

(0.140)

(0.400)

(2.290)

Other Adjustments

0.000

0.000

0.000

0.000

Net Profit

175.980

207.460

74.810

(21.390)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

5.79

3.90

4.90

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

9.22

6.51

7.75

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

12.09

10.60

10.57

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.34

0.32

0.32

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.75

1.96

1.98

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.43

2.56

2.45

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Details of Sundry Creditors:

 

Particulars

 

31.03.2010

(Rs. in millions)

31.03.2009

(Rs. in millions)

31.03.2008

(Rs. in millions)

Sundry Creditors

1094.581

883.916

811.047

 

 

 

 

 

HISTORY:

 

Subject [formerly West Coast Oxygen Limited] is engaged in manufacture and trading of Pesticides. The agri business of Excel Industries Limited was transferred to and vested with ECCL as a going concern w.e.f April 1, 2002. It may be recalled that prior to the scheme of arrangement, ECCL was operating as a wholly owned subsidiary of EIL under its earlier name West Coast Oxygen (WCOL). Hence this is the 39th AGM of the company. The name was changed from WCOL to ECCL with effect from 30th January 2003. Further as per the scheme of arrangement ECCL has issued to the shareholders of EIL one equity share of Rs 5/- each fully paid-up for every one equity share of Rs 5/- each held by them in EIL. The paid-up equity capital after completion of entire demerger process stood at Rs.55.000 Millions. The company's product are being exported to most of the countries in the world. The new market recently added by the company are Latin America and Africa. The company has taken various initiatives on development of new value added branded formulations in the existing molecules and new molecules in the area of Herbicides and Acaricides. In terms of markets, the company has already made inroads indo new geographics particularly Latin America and West Africa. The company has been making investments in data generation and registrations for the domestic and international markets. The company has been putting special emphasis on total agriculture focussing on solutions rather than merely selling products, and encompassing the entire value chain from farmers to ultimate consumers and the processors and intermediates in between.

 

OPERATIONS:

 

During the year, the net sales decreased from Rs.6851.000 millions in the previous year to Rs.6204.100 millions. Domestic sales marginally increased from Rs.3915.500 millions in the previous year to Rs.4039.600 millions in the year whereas the export turnover dropped sharply by 26% from Rs.2935.500 millions to Rs.2164.500 millions.

 

Sharp drop in price of Glyphosate, a major weedicide product of the Company, in the international market was the major reason for the fall in exports. In the domestic market, the sales offtake was higher. However, prices of several of the Company’s products were significantly lower in comparison to the previous year. The lower sales realisation was, however, compensated by lower input costs and did not reduce profitability.

 

The Company’s profit before tax in the year has increased to Rs.571.900 millions from Rs.446.000 millions in the previous year mainly for the reason that in the previous year the Company had an abnormal and large foreign exchange/derivative loss of Rs.324.200 millions whereas in the year there is a foreign exchange gain of Rs.3.000 millions.

 

NEW PRODUCTS:

 

During the year, the Company introduced a new rust fungicide in the international market. This product is proposed to be introduced in the domestic market as well. The Company also introduced an acaricide which is well received in the market. To meet the changing market requirements, the Company has been increasing its retail pack range and augmenting and modifying its packaging facilities. The Company continues its efforts at energy conservation and energy cost reduction.

 

OUTLOOK:

 

The agriculture sector in India continues to receive focused attention from the Central as also the State Governments. Crop failure last year and the resultant food shortages and food price inflation once again highlighted the importance of this sector for the country’s economy. The private sector has been making significant investments in farming and rural sectors as these segments are seen as future growth drivers for the economy. Farmers are receiving attractive price for their produce and are able to spend on quality farm inputs. The Indian agriculture sector and the rural economy continue to grow at a steady and satisfactory pace. With one more near-normal monsoon forecast for the current year, the short-term outlook for the agrochemicals industry and the Company appears reasonably good. The Company continues to focus on growth of its branded products. Exports continue to remain the focus area of growth for the Company. The Company strives to make up for the ground lost in the year in the export arena. At the same time the Company remains conscious about the high credit risk associated with some geographies in the export markets. The Company continues to make efforts to explore and penetrate new export markets.

 

TRANSFER OF SEEDS BUSINESS TO EXCEL GENETICS LIMITED:

 

The Company transferred its seeds business as a going concern to Excel Genetics Limited (formerly, Harvest Inte-Agro Limited) with effect from 1st July, 2009 by transfer of fixed and current assets, liabilities and provisions, trade marks, copyrights, licences, registrations, contracts, etc. relating to the seeds business at book value. The services of employees of the seeds business were also transferred to Excel Genetics Limited. The Company acquired 75% stake in Excel Genetics Limited by subscribing to its 1,50,000 equity shares of Rs. 10/- each at par and it thus became the Company’s subsidiary.

 

MANAGEMENT DISCUSSION AND ANALYSIS

 

Industry Structure and Developments:

 

The Company is engaged in the business of agrochemicals comprising insecticides, weedicides, fungicides, fumigants and rodenticides. The Company’s product basket also includes Soil Enricher, Bio-Pesticides and Plant Growth Promoters. During the year the Company transferred its seeds business to Excel Genetics Limited which is now a subsidiary company.

 

Among the agrochemicals, insecticides have dominated consumption pattern in India. However, its share is steadily declining year after year owing to introduction of genetically modified crops such as cotton and increasing consumption of weedicides and fungicides which are witnessing fast growth. Cotton crop used to be the single largest consumer of agrochemicals in India. However, with the advent of genetically modified cotton crop, the picture has drastically changed. Rice, wheat, soybean, pulses, plantation crops, fruits and vegetables have emerged as major consumers of agrochemicals. Food shortages and food price inflation seen across the world in past few years has brought focus on efficient and effective storage of food grains which can balance demand-supply gaps from year to year and provide for a stable price regime. This has brought about renewed focus on ‘post-harvest crop protection products’ like fumigants and rodenticides. These products are forging good growth in the past few years.

 

The fortunes of the agrochemicals industry are interwoven with the fortunes of agriculture. With the relatively slow pace of agricultural growth in India, the agrochemicals industry too is growing at a low rate.

 

The industry comprises of diverse players ranging from small and medium ones dealing in generic molecules to large multinationals with high-priced new generation molecules and patented products.

 

The industry has built up large capacities in India and has many manufacturers, especially in formulation business and has a fairly high level of competition. The seasonal nature of the business and the climatic uncertainties compel the industry to carry a large inventory for long periods. Domestic market has been attracting attention of multinationals who visualise good growth opportunity in the domestic market. The domestic industry has been witness to a steady increase in market share by new generation and patented molecules.

 

Supply of high quality products at competitive prices, development of new products/formulations and product registration are emerging as key success factors.

 

The domestic industry is continuously striving to increase exports by providing quality products at competitive prices with a view to ensure better utilisation of capacities as also to hedge against uncertain climatic conditions within the country. Over the years, India has emerged as a significant supplier of agrochemicals in the international market. Globally the agrochemicals business is stable and not growing much and this leads to intense competition, especially in generic molecules segment, which manifests in dropping prices and declining industry margins.

 

Opportunities and Threats:

 

Agriculture is the mainstay of rural economy and supports over two-thirds of the country’s population. It continues to receive attention of the Central and State Governments through favourable agriculture policies, minimum support price for major produces, subsidies, developmental programmes and schemes and availability of credit and finance through various schemes.

 

With decent minimum support prices and attractive open market prices for several crops, the farmers are receiving remunerative price for their produce. With increasing purchasing power in hand, the farmers afford to spend on better farm inputs as well as for personal consumption. Private sector also visualises good growth potential for investment in agriculture and agro-based businesses. Rapidly developing food processing industry is helping in large measure the growth of the farming sector. Steady performance of the rural economy in the face of recent sluggishness in other segments of the country’s economy is another factor attracting attention of the private sector to rural areas in general and to agriculture in particular.

 

With large food grain stocks being carried by the government organizations and the food processing industry, the demand for post-harvest crop protection chemicals is rising. Farmers have also acquired stock holding capacity and wait for right price in market. This also increases demand for such products.

 

All these factors point to reasonably good growth prospects for agriculture and, by logical extension, for the agrochemicals industry. Pesticides consumption in India is very low by the world consumption standard and there is scope for increasing the same by making their judicious use. Amongst the States also there are large variations in per acre pesticide consumption. All these factors underline untapped growth potential in the domestic market.

 

Genetically modified (GM) cotton crop now accounts for a large share of the cotton acreage in India. New varities of GM cotton seeds are being introduced which further increase GM cotton crop acreage. GM cotton has adversely impacted consumption of some insecticides which target cotton-specific pests. However, GM cotton crop does need protection against other pests and this opens up opportunity for some different variety of insecticides. Also a GM crop needs good nurturing to make it economically viable and this has opened opportunity for growth of weedicides and soil nutrients products.

 

The Company, with its vast experience in pest control practices, wide product range and efficient and effective distribution network, has been taking various steps like launching new products and formulations, introduction of combi-products, improving processes to enhance yield and quality and reducing costs in order to maintain its lead in the industry and stay competitive. In the year, the Company introduced an acaricide molecule in the domestic market and a new fungicide in the international market. The Company continues to offer new and innovative products for weed control. The Company’s weedicide product range is gaining new markets and customers and to meet with the increasing market demand the Company has plans to expand production capacity for weedicides and their formulations.

 

The Company’s ‘post-harvest crop protection products’ are posting good growth in domestic and international markets. The Company has also been introducing new generation products and enlarging its product portfolio.

 

The Company strives at finding application of its products for the newer crops through field trials and thereby widen coverage for its existing products to more crops. The Company also markets bio technology products such as Soil Enricher, Bio- Pesticides and Plant Growth Promoters. These products, though small in market size, have niche market position and hold good growth potential. This product group is useful in the area of plant and soil nutrition, organic farming and soil health management – the areas of interest for the Company. The Company has a state-of-the-art soil health research laboratory to analyse soil composition and assess soil health and to develop products for soil rejuvenation and nutrition.

 

The export market continues to offer good growth opportunities to the Company. The Company has been strengthening its presence in the overseas market by exploring new markets, promoting existing and new products, especially branded products, protecting its existing product registrations and making investment in new product registrations. Product registration acts as an entry barrier in a new export market and it is vital to continue investing in new product registrations and protecting the existing ones. The Company continues to explore opportunity for its products in new geographies and makes concerted efforts for product registration in these countries with a view to entering new markets.

 

Segment-wise performance and outlook:

 

The Company’s domestic sales increased from Rs.3915.500 millions in the previous year to Rs.4039.600 millions in the year. Exports however reduced from Rs.2935.500 millions in the previous year to Rs.2164.500 millions in the year.

 

With increasing emphasis on agriculture in public policies, increasing purchasing power in the hands of farmers and near normal monsoon forecast, the current year outlook for the industry and the Company appears reasonably good.

 

A strong brand gives market depth and long term advantages in terms of strong and consolidated market position. Over the years, the Company has made sustained efforts at brand building. This has yielded good results and today branded products dominate the Company’s sales turnover accounting for about two-thirds of the turnover. Branded products, however, require higher investment in inventories and book debt. The Company has a strong network of dedicated distributors and dealers many of whom have decades-long association with the Company. The Company has been quick in responding to changing demand for retail pack and has built up packaging facilities suitably.

 

The Company has been working closely with farmers, in India and several other countries, through its various programmes including ‘Excel and Me’ and ‘Excel Kisan Mitra’ and provides comprehensive package of products, services, knowledge and solutions to farmers. The Company has also set up phone helplines to provide help and advice to farmers on various farming subjects.

 

The initiatives taken by the Company in promoting Integrated Pest Management (IPM) and Integrated Crop Management (ICM) and its investment in brand promotion, developing closer ties with farmers and corporate image building are helping it in maintaining leading position in the industry. The Company’s recent initiatives in soil health management are bringing it further closer to the farmers.

 

Financial Performance and Analysis:

 

The net sales reduced from Rs.6851.000 millions in the previous year to Rs.6204.100 millions in the year. The profit before tax however increased from Rs.446.000 millions in the previous year to Rs.571.900 millions in the year.

 

NATURE OF OPERATIONS:

 

Subject is a reputed Company in agro chemicals sector manufacturing technical grade and formulations of pesticides. The Company also markets agri inputs like soil enrichers, bio-pesticides and plant growth promoters. The Company has presence in both the domestic and international markets.

 

MARCH 2011 AUDITED FINANCIAL RESULTS

 

SUMMARY OF AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH, 2011

(Rs. in millions)

 

 

Stand alone basis

Sr. No.

Particulars 

Year Ended
31st March,
2011

1

Sales

7490.165

2

Excise Duty

467.395

3

Net Sales

7022.770

4

Other Operating Income

288.720

5

Total Income

7311.490

6

Total Expenditure

 

 

(a) (Increase)/Decrease in Stock

76.856

 

(b) Consumption of Raw Materials

3204.461

 

(c) Purchase of Traded Goods

572.944

 

(d) Personnel Cost

508.870

 

(e) Depreciation 

109.508

 

(f) Other Expenditure

2049.786

 

Total Expenditure

6522.425

7

Profit from Operations before Other Income, Interest and Exceptional items

789.065

8

Other Income

17.000

9

Profit before Interest and Exceptional items

806.065

10

Interest

81.538

11

Profit Before Taxation, Exceptional items and Prior Period Adjustments 

724.527

12

Exceptional item

102.000

13

Profit Before Taxation and Prior Period Adjustments

622.527

14

Provision for Taxation  - Current

228.000

 

                                - Deferred

(44.809)

15

Profit Before Prior Period Adjustments

439.336

16

a) Prior Period Adjustments

(2.492)

 

b) Excess Provision for Taxation for earlier years

0.017

17

Minority interest

 

18

Share of Profit / (Loss) in Associate Company

 

19

Net Profit 

436.861

20

Paid-up Equity Share Capital (Face value  Rs. 5/- per 
Equity Share)

55.028

21

Reserves excluding Revaluation Reserves (as per the Balance Sheet)

2021.936

22

Basic and Diluted Earning per Share (Rs.)

39.69

23

Public Shareholding:

 

 

- No. of Shares

8886641

 

- Percentage of Shareholding

80.75%

24

Promoters and promoter group Shareholding

 

 

a)  Pledged/Encumbered

 

 

    - Number of shares

40600

 

- Percentage of shares (as a % of the total shareholding of promoter and promoter group)

1.92%

 

- Percentage of shares (as a % of the total share capital of the Company)

0.37%

 

b)  Non-encumbered

 

 

    - Number of shares

2078389

 

  - Percentage of shares (as a % of the total shareholding of promoter and promoter group)

98.08%

 

  - Percentage of shares (as a % of the total share capital of the Company)

18.88%

 

STATEMENT OF ASSETS AND LIABILITIES

(Rs. in millions)

 

 

Stand alone basis

Sr. No.

Particulars 

Year Ended
31st March,
2011

 

(a) Share Capital

55.028

 

(b) Reserves and Surplus

2021.936

2

Minority Interest

              -  

3

Deferred Government Grants

3.941

4

Loan Funds

1225.851

5

Deferred Tax Liability

92.871

 

Total

3399.627

 

 

 

1

Fixed Assets

1209.373

2

Intangible Assets

27.204

3

Deferred Tax Asset

              -  

4

Investments

72.126

5

Current Assets, Loans and Advances:

 

 

(a) Inventories

1395.462

 

(b) Sundry Debtors

1498.410

 

(c) Cash and Bank balances

85.010

 

(d) Other Current Assets

126.373

 

(e) Loans and Advances

356.753

 

Less: Current Liabilities and Provisions:

 

 

(a) Liabilities

1176.677

 

(b) Provisions

194.407

 

Net Current Assets

2090.924

6

Miscellaneous Expenditure

              -  

 

Total

3399.627

 

NOTES:

 

1. The Board of Directors have recommended a dividend of Rs.3.75 per equity share of Rs.5/- each.

 

2. On a writ petition filed by Democratic Youth Federation of India against the Union of India and State Governments seeking a ban on Endosulfan (a major product of the Company) citing health concerns, the Hon’ble Supreme Court opined that a detailed study on an all India basis needed to be undertaken by an Expert Committee to address the said health concerns.  By an ad-interim order passed on 13th May 2011, the Hon’ble Supreme Court has appointed a Joint Committee headed by the Director General of Indian Council of Medical Research and the Commissioner (Agriculture) to conduct a scientific study and submit its interim report within eight weeks. Pending submission of the interim report, the order bans the production, use and sale of Endosulfan all over India till further orders.


In compliance with the ad-interim order of the Hon’ble Supreme Court, the Company immediately suspended production and sale of Endosulfan. As the ad-interim order has been issued during the peak sale season, the performance of the Company in the short term will be adversely affected. The Company is revising its sales plan and marketing strategy and also undertaking other measures to mitigate the adverse impact.

Out of abundant caution, a provision of Rs.102.000 millions has been made in respect of the inventory items relating to Endosulfan as at 31st March, 2011.         

 

3. The Company has only one primary business segment viz. Agri Inputs. 

 

4. In the Consolidated Results for the year ended 31st March, 2011, the  effect  of  investment  in  Aimco Pesticides Limited, an associate company, has been considered on the basis of its unaudited financial results whereas  the Accounting Standard (AS) 23 ‘Accounting for Investments in Associate Companies in Consolidated Financial Statements’ requires that the same be considered on the basis of audited financial results. The amount of the share of loss so considered on the basis of unaudited results is Rs.1.779 millions.       

 

5. In March, 2011, the Company has established a wholly owned subsidiary named Excel Brasil Agronegocios Ltda in Brazil.           

 

6. The figures for the previous year have been regrouped wherever necessary.        

 

7. There were 2 investor complaints pending as on 1st January, 2011.  The Company received 4 investor complaints during the quarter ended 31st March, 2011. All the complaints were resolved during the quarter.         

 

8. The above results as reviewed by the Audit Committee have been approved at the meeting of the Board of Directors held on 25th May, 2011.       

 

CONTINGENT LIABILITIES:

 

Particulars

31.03.2010

(Rs. in millions)

(a) Disputed Excise-duty liability

0.277

(b) Disputed Service-tax liability

3.445

(c) Disputed Income-tax liability

10.538

(d) Disputed Sales-tax liability

1.157

(e) Guarantees given by the Company’s bankers on behalf of the Company to third parties

7.946

(f) Liability in respect of employee(s) disputes

Amount

unascertainable

(g) Claims against the Company not acknowledged as debts

1.986

 

 

 

FIXED ASSETS

Tangible Assets

v      Land – Freehold

v      Land – Leasehold

v      Leasehold Improvement’s

v      Buildings

v      Plant and Machinery

v      Electrical Installations

v      Laboratory Equipments

v      Furniture, Fixtures and Office Equipments

v      Vehicles

v      Technical Books

Intangible Assets

v      Data Registration Expenses

v      Computer Software/ Licence Fees

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.44.89

UK Pound

1

Rs.73.85

Euro

1

Rs.64.76

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

7

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

6

--RESERVES

1~10

7

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

58

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.